Climate Finance

Reading the Theology of Presbyterian University and Theological Seminary in Terms of Public Relationship of the Church: Centering on Theological-Ethical Analysis and Evaluation of Theological Statements of PUTS

Korea Presbyterian Journal of Theology ◽

10.15757/kpjt.2018.50.1.007 ◽

2018 ◽

Vol 50 (1) ◽

pp. 195-222

Author(s):

Chang-Ho LEE

Keyword(s):

Ethical Analysis ◽

Theological Seminary ◽

Analysis And Evaluation ◽

Relationship Of ◽

The Church

Download Full-text

10.1596/27817 ◽

2010 ◽

Cited By ~ 1

Author(s):

Shilpa Patel

Keyword(s):

Climate Finance

Download Full-text

Climate Impact Measurement In Climate Finance and Carbon Markets

Carbon & Climate Law Review ◽

10.21552/cclr/2020/3/8 ◽

2020 ◽

Vol 14 (3) ◽

pp. 199-209

Author(s):

J. Macinante

Keyword(s):

Climate Impact ◽

Climate Finance ◽

Carbon Markets ◽

Impact Measurement

Download Full-text

Dilemmas of nudging in public health: an ethical analysis of a Danish pamphlet

Health Promotion International ◽

10.1093/heapro/daaa146 ◽

2020 ◽

Author(s):

Jacob Busch ◽

Emilie Kirstine Madsen ◽

Antoinette Mary Fage-Butler ◽

Marianne Kjær ◽

Loni Ledderer

Keyword(s):

Public Health ◽

Ethical Issues ◽

Screening Programme ◽

Screening Program ◽

Ethical Analysis ◽

Choice Making ◽

The Face ◽

Information Materials ◽

The Individual ◽

To Receive

Summary Nudging has been discussed in the context of public health, and ethical issues raised by nudging in public health contexts have been highlighted. In this article, we first identify types of nudging approaches and techniques that have been used in screening programmes, and ethical issues that have been associated with nudging: paternalism, limited autonomy and manipulation. We then identify nudging techniques used in a pamphlet developed for the Danish National Screening Program for Colorectal Cancer. These include framing, default nudge, use of hassle bias, authority nudge and priming. The pamphlet and the very offering of a screening programme can in themselves be considered nudges. Whether nudging strategies are ethically problematic depend on whether they are categorized as educative- or non-educative nudges. Educative nudges seek to affect people’s choice making by engaging their reflective capabilities. Non-educative nudges work by circumventing people’s reflective capabilities. Information materials are, on the face of it, meant to engage citizens’ reflective capacities. Recipients are likely to receive information materials with this expectation, and thus not expect to be affected in other ways. Non-educative nudges may therefore be particularly problematic in the context of information on screening, also as participating in screening does not always benefit the individual.

Download Full-text

Medication of Hydroxychloroquine, Remdesivir and Convalescent Plasma during the COVID-19 Pandemic in Germany—An Ethical Analysis

International Journal of Environmental Research and Public Health ◽

10.3390/ijerph18115685 ◽

2021 ◽

Vol 18 (11) ◽

pp. 5685

Author(s):

Katja Voit ◽

Cristian Timmermann ◽

Florian Steger

Keyword(s):

Early Stage ◽

Treatment Options ◽

Drug Distribution ◽

Experimental Treatment ◽

Ethical Analysis ◽

Ethical Principles ◽

Ethical Challenges ◽

Ethical Guidelines ◽

Negative Effects ◽

Experimental Drug

This paper aims to analyze the ethical challenges in experimental drug use during the early stage of the COVID-19 pandemic, using Germany as a case study. In Germany uniform ethical guidelines were available early on nationwide, which was considered as desirable by other states to reduce uncertainties and convey a message of unity. The purpose of this ethical analysis is to assist the preparation of future guidelines on the use of medicines during public health emergencies. The use of hydroxychloroquine, remdesivir and COVID-19 convalescent plasma in clinical settings was analyzed from the perspective of the ethical principles of beneficence, non-maleficence, justice and autonomy. We observed that drug safety and drug distribution during the pandemic affects all four ethical principles. We therefore recommend to establish ethical guidelines (i) to discuss experimental treatment options with patients from all population groups who are in urgent need, (ii) to facilitate the recording of patient reactions to drugs in off-label use, (iii) to expand inclusion criteria for clinical studies to avoid missing potentially negative effects on excluded groups, and (iv) to maintain sufficient access to repurposed drugs for patients with prior conditions.

Download Full-text